<a href=Nonin Medical” height=”327″ src=”https://www.medicaldevice-network.com/wp-content/uploads/static-progressive/nri/medicaldevice/news/get_logo.cgi_PRN-NONIN-MEDICAL-INC-EQUANOX-ADVANCE-8004CB-yh_original.jpg” style=”padding: 10px” width=”300″ />Nonin Medical, a manufacturer of non-invasive medical monitoring solutions, has launched the Equanox Advance Model 8004CB series neonatal / paediatric sensor in the US.

The cerebral / somatic sensor, with Nonin’s patent-pending dynamic compensation algorithm, is designed to automatically account for paediatric brain-tissue-development variation when measuring oxygen saturation levels.

Kevin McGowan, Nonin Medical global sales vice president, said that until now, paediatric cerebral / somatic oximetry sensors have essentially been trimmed versions of adult sensors.

"With the help of the device, clinicians can react to reverse harmful tissue ischemia events before they become critical."

"The sensor features adhesive and non-adhesive versions for delicate skin, a small footprint for space-saving placement, short light-path spacing for paediatric-appropriate tissue-depth readings, and Nonin’s dynamic compensation algorithm for calculating accurate, patient-specific values," McGowan added.

"And because the 8004CB provides a single-sensor solution for all patients less than 40kg, it simplifies protocols and inventory requirements, saving time and money."

The sensors are used with Nonin’s Equanox Advance Model 7600 oximetry system in cerebral or somatic positions on patients weighing less than 40kg.

The near infrared spectroscopy (NIRS)-based monitoring device noninvasively and continuously detects oxygen saturation status in the brain and other tissue.

With the help of the device, clinicians can react to reverse harmful tissue ischemia events before they become critical, according to the company.

Dean Kurth, Cincinnati Children’s Hospital Medical Center’s anaesthesiologist-in-chief, said Nonin’s Equanox Advance 8004CB sensor provides absolute accuracy of cerebral oxygenation status without requiring the physician to input patient demographics or stock and choose from multiple sensors.

"Nonin’s new 8004CB sensor, with its dynamic compensation algorithm, is the first sensor to automatically adjust for paediatric brain myelination changes," Kurth added.

The Equanox Advance 8004CB and 8004CB-NA (non-adhesive) neonatal / paediatric sensors, along with the Model 7600 oximetry system, provide additional advantages such as patented dual-light emitters and detectors with four wavelength accuracy, portability and connectivity.

Image: EQUANOX Advance Model 8004CB series neonatal / paediatric sensor will detect oxygen saturation status in brain and other tissue. Photo courtesy of: Nonin Medical.